1.82
Codexis Inc Borsa (CDXS) Ultime notizie
Analyst sentiment unchanged after Codexis (CDXS) earnings - msn.com
Codexis Faces Critical Commercialization Phase - AD HOC NEWS
CEO Moves: Should I invest in Codexis Inc before earningsPrice Action & Safe Entry Point Alerts - baoquankhu1.vn
CDXS Stock Price, Quote & Chart | CODEXIS INC (NASDAQ:CDXS) - ChartMill
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Vanguard disaggregates holdings; Codexis Inc (NASDAQ: CDXS) shows 0 shares - Stock Titan
Institution Moves: Will Codexis Inc benefit from rising consumer demandQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Analyst Sentiment Unchanged After Codexis (CDXS) Earnings - Insider Monkey
Codexis rises after Q4 beat, strong outlook - MSN
Benchmark reiterates Hold on Codexis stock after Q4 results By Investing.com - in.investing.com
Benchmark reiterates Hold on Codexis stock after Q4 results - Investing.com
Four Stocks at the Intersection of Enzymes, Longevity, and the $400 Billion Wellness Boom (CELV, NAGE, MTEX, CDXS) - marketscreener.com
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Biocatalysis Market Accelerates with Rising Demand - openPR.com
Jobs Data: Does Codexis Inc offer margin of safety2026 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
Fund Flows: Is Codexis Inc stock technically oversold2026 Chart Watch & Weekly High Return Stock Opportunities - baoquankhu1.vn
Biocatalysis and Biocatalysts Market is expected to Hit US$ 6.7 - openpr.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue GuidanceHas The Bull Case Changed? - simplywall.st
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2% - MarketBeat
Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance - Yahoo Finance
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
Codexis Stock Plummets Amid Financial Struggles - StocksToTrade
Why did CDXS stock jump 7% today? - MSN
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Sahm
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Sahm
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Sahm
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - simplywall.st
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com UK
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):